Evaluation of circulating tumour cells expressing CD44 variants in the blood of gastric cancer patients by flow cytometry

Anticancer Research

Volumn 18, Issue 5 B, 1998, Pages 3747-3752

  Pituch Noworolska, Anna ^a   Wiȩckiewicz, Jerzy ^a   Krzeszowiak, Agnieszka ^a   Stachura, Jerzy ^b   Ruggiero, Irena ^a   Gawlicka, Małgorzata ^a   Szczepanik, Antoni ^b   Karcz, Danuta ^b   Popiela, Tadeusz ^b   Zembala, Marek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

CD44 variants; Circulating tumour cells; Flow cytometry; Gastric cancer

Indexed keywords

CA 72-4 ANTIGEN; CD44V ANTIGEN; CD45 ANTIGEN; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CELL SELECTION; CIRCULATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; ANTIGENS, CD45; ANTIGENS, NEOPLASM; CA-15-3 ANTIGEN; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031646518     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Campana D, Pui Ch-H: Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance. Blood 85: 1416-1434, 1995.
2. Sievers EL, Loken MR: Detection of minimal residual disease in acute myelogenous leukemia. J Ped Hematol/Oncol 17: 123-133, 1995.
3. van Dongen JJM, Breit TM, Adriaansen HJ, Beishuizen QA, Hoojikaas H: Detection of minimal residual disease in acute leukemia by immunological markers analysis and polymerase chain reaction. Leukemia 6: 47-59, 1992.
4. Brandt B, Junker R, Griwatz C, Heidl S, Brinkmann O, Semjonow A, Assmann G, Zanker KS: Isolation of prostate-derived single cells and cell clusters from human peripheral blood. Cancer Res 56: 4556-4561, 1996.
5. Schlimok G: Epithelial tumour cells in bone marrow: detection, prognostic significance, characterization and therapeutic approaches. Cytometry, suppl. 8, abstr. IH11, 1996.
6. Zingler M, Broll R, Lembcke K, Stock C, Duchrow M, Bruch H-P: Immunocytochemical detection of tumor cells in bone marrow and peritoneal lavage in patients with gastrointestinal cancer. Anticancer Research, abstr. 423, 1995,.
7. Pantel K, Izbicki J, Passlick B, Angstwurm M, Haussinger K, Thetter O, Riethmuller G: Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 347: 649-653, 1996.
8. Merkle E, Bahr J, Henke A, Buhner M, Martus P: Immunocytochemical detection of tumor cells in bone marrow as a prognostic factor in breast carcinoma. Geburtshilfe-Frauenheilkd 54: 662-669, 1994.
9. Hurwitz CA, Gore SD, Stone KD, Civin CI: Flow cytometry detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells. Leukemia 6: 233-239, 1992.
10. Syrjala M, Anttila V-J, Ruutu T, Jansson S-L: Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens. Leukemia 8: 1564-1570, 1994.
11. Radbruch A, Rectenwald D: Detection and isolation of rare cells. Current Opinion in Immunol 7: 270-273, 1995.
12. Johnson PG, Allegra CJ: Colorectal cancer biology: Clinical implications. Seminars in Oncology 22: 418-432, 1995.
13. Nossal GJV: Minimal residual disease as the target for immunotherapy of cancer. Lancet 343: 1172-1173, 1994.
14. Guadagni F, Roselli M, Amato T, Cosimelli M, Mannella E, Perri P, Abbolito MR, Cavaliere R, Colcher D, Greiner JW, Schlom J: Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. Cancer 68: 2443-2450, 1991.
15. Guadagni F, Roselli M, Cosimelli M, Mannella E, Tedesco M, Cavaliere F, Grassi A, Abbolito MR, Greiner JW, Schlom J: TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer. Cancer 72: 2098-2106, 1993.
16. Heider K-H, Dammrich J, Skroch-Angel P, Muller-Hermelink H-K, Vollmers HP, Herrlich P, Ponta H: Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 53: 4197-4203, 1993.
17. Rudzki Z, Jothy S: CD44 and the adhesion of neoplastic cells. J Clin Pathol: Mol Pathol 50: 57-71, 1997.
18. Tanabe KK, ElHs LM, Saya H: Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 341: 725-726, 1993.
19. Kryworuckho M, Diaz-Mitoma F, Kumar A: CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells. Immunology 86: 41-48, 1995.
20. - cells. Journal Molecular Medicine 1: 573-578, 1998.
21. Delsol G, Al Saati T, Gatter KC, Gerdes J, Schwarting R, Caveriviere P, Rigal-Huguet F, Robert A, Stein H, Mason DY: Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Am J Pathol 130: 59-70, 1988.
22. Sloane JP, Ormerod MG: Distribution of epithelial membrane antigen in normal and neoplastic tissues and its value in diagnostic tumor pathology. Cancer 47: 1786-1795, 1981.
23. Schwaibold H, Wenck S, Huland E, Huland H: Immunocytologic staining of cytokeratin in bone marrow aspirates to detect micrometastatic cells fails in patients with metastatic urologic carcinoma. Int J Oncol 11: 1197-1201, 1997.
24. Koopman G, Heider K-H, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST: Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177: 897-904, 1993.